Tag: Amgen
FTC Sues To Stop Amgen’s $27.8 Billion Horizon Therapeutics Buy
The Federal Trade Commission has filed a lawsuit to prevent Amgen's acquisition of Horizon Therapeutics, citing concerns about potential competition limitations in the pharmaceutical...
Amgen, Teva Get Can Appeal Sensipar Antitrust Ruling
Amgen and Teva Pharmaceuticals Industries have been granted permission for an expedited appeal in an antitrust case related to Amgen's Sensipar, a calcium reducer,...
Warren Sends Letter To FTC Over Amgen & Indivior Deals
Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the US Federal Trade Commission to express concern about two pending pharmaceutical deals.
In...
Amgen To Buy Rival Horizon Therapeutics For $27B
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion.
Each...
Amgen Files Motion To Dismiss Regeneron Antitrust Suit
In May, Regeneron filed an antitrust suit that alleged Amgen conducted a bundling scheme that allowed the company to charge low prices with which...
Humira Generic Delay Case Against AbbVie, Amgen, Sandoz Appealed
AbbVie, Amgen (a Samsung subsidiary), and Novartis unit Sandoz will face an appeal to the Seventh Circuit of antitrust claims over patent infringement settlements...
